When Aerospace Capex Meets SME Execution: Sigma's Defense Inflection

The three events form a coherent narrative: capital (₹460 Cr raise) - capability (Bromford acquisition, Rolls-Royce LTA) - cash flow (shell order + LTA ramp). Most equity research covering Sigma this week focused on Q1 results headlines (revenue +16%, EBITDA +11%). The investment thesis, however, is structural: Sigma is graduating from a sub-tier-2 defense supplier to a Tier-1 adjacent manufacturer with $100M+ annual contracts and multi-year OEM relationships. The stock's sensitivity to this inflection is the angle; the results are merely confirmation of timing.

In June 2026, Sigma raised ₹460 crore via preferential allotment at ₹347 per share. At the time, most commentary was transactional: dilution concerns, fund utilization timing. The actual deployment tells the story. Within three weeks, the company announced Bromford acquisition (₹153 crore) and the Rolls-Royce LTA (unlocking ₹3,000+ crore nominal pipeline). By month-end July, the artillery shell order (USD 105M) provided the near-term cash-generation story. The capex raise was not opportunistic dilution - it was deliberate sequencing.

The FY27 P&L question is not whether Sigma grows, but how much margin it preserves while ramping high-volume, lower-margin shell manufacturing. Q1 already shows this trade: revenue +16%, but EBITDA +11% (margin compression from 17.0% in Q4 to 16.3% in Q1). The shell order will likely widen this gap in the near term. But the Rolls-Royce LTA - higher margin, higher volume over 3-5 years - is the offset. By FY28-FY29, when both orders reach steady-state, the consolidated OPM should re-expand to 17-18%, supported by Bromford synergies.

Sigma completed acquisition of Bromford Precision Solutions (UK) for GBP 11.89 million (~₹153 crore) in late July 2026. Bromford is a 50-year-old aerospace precision manufacturer - specialist in aeroengine rings, casings, and structural components. The deal values Bromford at 4.6x adjusted EBITDA, a market-rate multiple for a profitable, contract-backed manufacturing business. Here's the strategic logic:

1. 1

   Instant Tier-1 credentials

   Bromford already supplies Rolls-Royce (via prior relationships). Owning Bromford gives Sigma a direct seat at the table and access to Rolls-Royce's approved vendor network - something Sigma's India-only footprint could not access in years.

2. 2

   De-risk the LTA

   The GBP 300M Rolls-Royce LTA was signed after Bromford acquisition. Ownership of a proven UK manufacturing partner made Sigma credible for a multi-year, high-volume contract. Bromford's track record is the collateral.

3. 3

   Cost arbitrage + automation

   Bromford currently operates in the UK (high labor cost, ~GBP 40-50k annual wage). Sigma's stated playbook: transition high-margin standard components to India (₹15-20 lakh annual wage), upskill Bromford's UK team to focus on R&D, complex engineering, and quality assurance. Potential 30-40% COGS reduction on high-volume skus.

4. 4

   Expand addressable market

   Bromford has 50-year relationships with UK OEMs (Rolls-Royce, GE, Sikorsky). Sigma's India presence can now serve these customers from lower-cost locations, and cross-sell defense contracts (e.g., artillery shells to UK/NATO customers) via Bromford's regulatory approvals.

Integration risk: The classic M&A trap - stellar standalone operations often underperform post-acquisition due to management friction, cost-cutting backlash, or customer attrition. Bromford has been independent for 50 years and operates in a quality-obsessed industry. Sigma will need to prove it can own and grow the business without destroying the culture that made it valuable. This is a 12-24 month execution test; Q2-Q3 FY27 earnings calls will show the early integration health.

The headline metric is EPS: ₹2.01 consolidated for Q1 FY27 vs. ₹7.29 in Q4 FY26. The 73% decline is not profit collapse - it's the impact of equity dilution from the capital raise and acquisition amortization. Underlying consolidated net profit (₹35.4 Cr in Q1 FY27) is healthy and growing. The EPS decline is mechanical: more shares outstanding. This is a classic feature of equity-funded M&A; investors should look through the EPS noise to net profit and EBITDA.

The shell order will likely compress margins in FY27, but the Rolls-Royce LTA - higher margin, longer duration - is the three-year offset.

Sigma trades at a significant premium to state-owned BEL and HAL, despite being smaller and less diversified. The premium is the market's bet on: (a) the Rolls-Royce LTA's reality, (b) Bromford integration success, (c) defense export momentum. If any of these slip, multiple compression is a real risk. Conversely, if Sigma executes the LTA ramp and achieves ₹2,000+ crore annual revenue by FY29, the multiple will compress to 20-25x P/E (in line with peers), but absolute value will more than double.